This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HARVEY SHIELDS COLLINS, M.D.; THOMAS M. GOCKE, M.D.; MAXWELL FINLAND, M.D.

Arch Intern Med. 1949;84(6):875-890.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE activity of aureomycin includes a wider variety of the known causative agents of pneumonia than that of any of the earlier effective chemicals or antibiotics¹. Clinical trials were, therefore, undertaken of the use of aureomycin in all types of nontuberculous pneumonia and other severe acute infections of the respiratory tract that were available for study. In separate communications, we have presented the results of aureomycin treatment in cases of primary atypical (virus) pneumonia,² in cases of pneumococcic pneumonias³ and in a variety of other cases which includes influenza and other severe acute infections of the respiratory tract and pneumonias in which a likely causative bacterial agent could not be identified.⁴ In this paper are presented the results of aureomycin therapy in cases of the nonpneumococcic and nontuberculous bacterial infections of the lungs.

MATERIALS AND METHODS

Selection of Cases.

—Two groups of cases were studied and . . . [Full Text PDF of this Article]

Author Affiliations
Milton Fellow, Harvard Medical School, and Research Fellow, Thorndike Memorial Laboratory; Research Fellow in Medicine, Harvard Medical School, and Research Fellow, Thorndike Memorial Laboratory; Associate Professor of Medicine, Harvard Medical School; Associate Physician, Thorndike Memorial Laboratory, and Chief, Fourth Medical Service, Boston City Hospital BOSTON

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School.

Footnotes
This study was aided by a grant from the United States Public Health Service.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?